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ABSTRACT
Staphylococcus lugdunensis is a rare cause of severe infections and clinical manifestations are 
similar to those related to S. aureus infection. We describe a hospital-acquired bacteremia due 
to methicillin-resistant Staphylococcus lugdunensis, misidentified as methicillin-resistant S. au-
reus. The oxacillin MIC was 16 µg/mL and the mecA gene and SCCmec type V were deter-
mined by PCR. Although treatment had been appropriated, the patient died after rapid pro-
gressive respiratory failure and another nosocomial sepsis. It is important not only to identify 
S. lugdunensis in view of its clinical course, but also to determine its susceptibility to oxacillin 
by detecting the mecA gene or its product.
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CASE REPORT
A 73-year old female with systemic arte-
rial hypertension and chronic obstructive 
pulmonary disease (COPD) GOLD IV was 
admitted to the Emergency Department of 
the University Hospital ‘Clementino Fraga 
Filho’ (HUCFF), in March 2005. HUCFF, a 
tertiary-care teaching hospital with 490 beds, 
is affiliated to the Federal University of Rio 
de Janeiro, Rio de Janeiro City, Brazil. The 
patient had asthenia, cough, fever, purulent 
secretions and worsening of dyspnea, but the 
chest x-ray showed no pulmonary infiltrates. 
Diagnosis of acute exacerbation and up-
per respiratory infection were made. Bron-
chodilators, glucocorticoids, gatifloxacin 
and non-invasive ventilation were initiated. 
Respiration did not recover, and mechani-
cal ventilation was needed. After completing 
the course of antimicrobial therapy the pa-
tient recovered. However, two cultures from 
blood collected at day 7 of therapy detected 
Gram-positive bacteria. Bacterial contami-
nation of blood was initially suspected since 
the patient had improved and precise iden-
tification of the sites of blood collection was 
not possible. Initially, methicillin-resistant 
S. aureus (MRSA) and Streptococcus alpha 
hemolytic were identified in the hospital lab-
oratory three days after blood collection and 
the strains were sent to our laboratory for 
confirmation. After the initial clinical im-
provement, the patient presented fever, leu-
cocytosis and hypotension. The central line 
catheter was removed, and vancomycin and 
amikacin were included in the treatment, 
according to the local microbiology pattern 
and the previous isolation. The nosocomial 
sepsis was probably related to the central line 
catheter,1 although abdominal imaging were 
not performed. The transthoracic echocar-
diogram result was normal. Another set of 
blood cultures drawn on the day when sepsis 
was diagnosed detected Escherichia coli and 
S. epidermidis. The patient had fast and pro-
gressive respiratory failure and despite in-
tense medical treatment she expired on day 
18 of hospitalization. 
The isolate obtained from the first blood 
culture was characterized as MRSA in the 
hospital laboratory by VITEK (BioMerieux). 
Gram staining, catalase test and latex agglu-
tination clumping factor and DNAse detec-
tion were performed as complementary tests. 
Antimicrobial susceptibility testing (VITEK, 
BioMerieux) revealed resistance to oxacillin, 
penicillin and chloramphenicol.
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In our laboratory, the isolate presented slightly yellow 
colonies and showed beta-hemolysis on sheep blood agar. 
It gave a positive reaction for clumping factor, but the tube 
coagulase test was negative. ! en, the isolate was evaluated 
using the method based on the conventional reference tests2 
and the ornithine decarboxylase production, an enzyme 
produced only by S. lugdunensis strains.3 To con! rm the 
species identi! cation, the fbl gene, which encodes a ! brino-
gen binding protein of S. lugdunensis was ampli! ed by PCR 
as previously published.2 A 425 bp amplicon was obtained 
a! er PCR ampli! cation of template DNA extracted from 
reference strain S. lugdunensis DSMZ 4804 and the clinical 
isolate. Antimicrobial susceptibility was evaluated accord-
ing to CLSI guidelines. ! e isolate was resistant to oxacillin, 
cefoxitin, penicillin and chloramphenicol by disk di! usion 
test. Oxacillin MIC, determined by the E-test method, was 
16 µg/mL. Initially, the mecA gene was detected by PCR, 
and the SCCmec typing was performed by multiplex 
PCR of the ccr type and mec class, using the method de-
scribed by Kondo et al.4 ! e isolate was ccr type 5 and mec 
class C, characterizing the SCCmec type V. ! e 804 bp 
amplicon (corresponding to ccr5 gene) and 518 bp (corre-
sponding to class C mec gene) generated in PCR reaction 
were con! rmed by sequencing and comparison with Gen-
Bank database.
! is is the ! rst case report of a methicillin-resistant S. 
lugdunensis (MRSL) isolate carrying the SCCmec type V 
causing a systemic infection. To our knowledge, this is the 
fourth report in the literature describing S. lugdunensis car-
rying the mecA gene. Kawaguchi et al.5 detected the mecA 
gene in one of two strains of S. lugdunensis isolated from 
blood during a laboratory surveillance in Japan, but no de-
scription of clinical infection was provided by them. In 2003, 
Tee et al.6 reported a case of MRSL causing bloodstream in-
fection in a neonate. In 2008, Tan, Ng and He7 found ! ve 
(4.7%) S. lugdunensis strains carrying the mecA gene in a 
collection of 106 clinical isolates. In Brazil, this is the ! rst 
report of a MRSL isolate.
S. lugdunensis was ! rstly described by Freney8 and is as-
sociated with several infections, mainly skin/so!  tissues in-
fections and endocarditis.9 In the clinical setting it frequently 
causes illness that has been described as acute, aggressive and 
destructive - more in keeping with coagulase-positive staphy-
lococci than characteristically indolent coagulase-negative 
staphylococcal infections, especially endocarditis, where the 
majority of infections involve native or prosthetic valves, be-
ing the mortality rates high.10 ! erefore, its aggressive nature 
resembles S. aureus. S. lugdunensis should be suspected when 
a staphylococcal isolate is positive in the clumping factor test 
but negative in the tube coagulase test.6 ! e isolation rates of 
S. lugdunensis are about 10% for non-S. epidermidis coagulase 
negative isolates.3 However, in a recent study, Böcher et al.11 
showed that the misidenti! cation of S. lugdunensis could be 
contributing to this low rate. ! ey improved the identi! cation 
of S. lugdunensis using the Columbia sheep-horse agar inocu-
lation as an additional test. To reinforce this fact we evalu-
ated the bacterial diagnostic provided for 5,360 blood cultures 
performed in our hospital, between 2000 and 2009 (data not 
shown). No S. lugdunensis isolate was detected, suggesting 
that this pathogen is being misidenti! ed. 
In the present case report we observed a clear misidenti! -
cation of a MRSL isolate as community MRSA. Both species 
present similar colony morphology and blood-agar hemoly-
sis. Interestingly, in addition to being positive by the clumping 
factor agglutination test, S. lugdunensis strains are also positive 
for DNAse, like S. aureus strains. ! is shows the importance 
to employ tube coagulase testing for staphylococcal character-
ization. For con! rmation the ornithine-decarboxylase test is 
also important, since S. lugdunensis is the only staphylococcus 
positive in this assay. ! e susceptibility pattern of the isolate 
indicated a community-associated pathogen. Only resistance 
for ! -lactams and chloramphenicol were observed. Moreover, 
this non-multiresistance has been related to the SCCmec type 
V, o! en found in community isolates. ! is case report con-
! rms the isolation of non-multiresistant S. lugdunensis carry-
ing the SCCmec V as a cause of a serious hospital-acquired in-
fection which was misdiagnosed as non-multiresistant MRSA 
in a setting with nosocomial transmission of the latter. 
REFERENCES
1.  Mermel LA, Allon M, Bouza E et al. Clinical practice 
guidelines for the diagnosis and management of intravas-
cular catheter-related infection: 2009 Update by the Infec-
tious Diseases Society of America. Clin Infect Dis. 2009; 
49:1-45.
2.  Pereira EM, Oliveira FL, Schuenck RP, Zoletti GO, dos 
Santos KR. Detection of Staphylococcus lugdunensis by a 
new species-specific PCR based on the fbl gene. FEMS Im-
munol Med Microbiol. 2010; 58:295-29.
3.  Herchline TE, Ayers LW. Occurrence of Staphylococcus lug-
dunensis in consecutive clinical cultures and relationship of 
isolation to infection. J Clin Microbiol. 1991; 29:419-21.
4.  Kondo Y, Ito T, Ma XX et al. Combination of multiplex 
PCRs for staphylococcal cassette chromosome mec type 
assignment: rapid identification system for mec, ccr, and 
major differences in junkyard regions. Antimicrob Agents 
Chemother. 2007; 51;264-74. 
5.  Kawaguchi E, Minamide W, Mori H, Igmi H. The taxo-
nomic distribution, characteristic and susceptibil-
ity against antimicrobial agents of methicillin-resistant 
staphylococci isolated from blood. Kansenshogaku Zasshi 
1996; 70:1147–53.
6.  Tee WS, Soh SY, Lin R, Loo L. Staphylococcus lugdunensis 
carrying the mecA gene causes catheter-associated blood-
stream infection in premature neonate. J Clin Microbiol. 
2003; 41:519-20.
7.  Tan TY, Ng SY, He J. Microbiological characteristics, presump-
tive identi! cation, and antibiotic susceptibilities of Staphylo-
coccus lugdunensis. J Clin Microbiol. 2008; 46:2393-5. 
S. lugdunensis carrying SCCmecV
295Braz J Infect Dis 2011; 15(3):293-295
Pereira, Schuenck, Nouér et al.
8.  Freney J, Brun Y, Bes M et al. Staphylococcus lugdunensis and 
Staphylococcus schleiferi sp. nov, two species from human 
clinical specimens. Int J Syst Bacteriol. 1988; 38:168-72.
9.  Frank KL, Del Pozo JL, Patel R. From clinical microbiology 
to infection pathogenesis: how daring to be di! erent works 
for Staphylococcus lugdunensis. Clin Microbiol Rev. 2008; 
21:111-133.
10.  Ebright JR, Penugonda N, Brown W. Clinical experience 
with Staphylococcus lugdunensis bacteremia: a retrospec-
tive analysis. Diagn Microbiol Infec Dis. 2004; 48:17-21.
11.  Böcher S, Tønning B, Skov RL, Prag J. Staphylococcus lug-
dunensis, a common cause of skin and soft tissue infec-
tions in the community. J Clin Microbiol. 2009;47:946-50. 
